Late effects in childhood cancer survivors and survivorship issues;Complicanze a lungo termine nei soggetti sopravvissuti a tumore in età pediatrica e problematiche a essi collegate

Epidemiologia e Prevenzione

Volumn 37, Issue 1, 2013, Pages 266-273

  Haupt, Riccardo ^a   Jankovic, Momcilo ^b   Hjorth, Lars ^c   Skinner, Rod ^d  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c LUND UNIVERSITY   (Sweden)

^d Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; CAUSE OF DEATH; CHILD; COMPLICATION; FEMALE; FOLLOW UP; FORECASTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; ITALY; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; ORGANS AT RISK; POSTOPERATIVE COMPLICATIONS; PRESCHOOL CHILD; RADIATION INJURIES; RADIOTHERAPY; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; ORGANS AT RISK; POSTOPERATIVE COMPLICATIONS; RADIATION INJURIES; RADIOTHERAPY; REGISTRIES; SURVIVORS; YOUNG ADULT;

EID: 84895852316     PISSN: 11209763     EISSN: 23851937     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Olsen JH, Moller T, Anderson H et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 2009;101(11):806-13.
2. Haupt R, Spinetta JJ, Ban I et al; International Berlin-Frankfurt-Münster Study Group Early and Late Toxicity Educational Committee (I-BFM-SG ELTEC). Long term survivors of childhood cancer: cure and care. The Erice statement. Eur J Cancer 2007;43(12):1778-80.
3. Oeffinger KC, Mertens AC, Sklar CA et al; Childhood Cancer Survivor Stury. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355(15):1572-82.
4. Geenen MM, Cardous-Ubbink MC, Kremer LCM et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007;297(24):2705-15.
5. Diller L, Chow EJ, Gurney JG et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol 2009;27(14):2339-55.
6. Armstrong GT, Liu Q, Yasui Y et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27(14):2328-38.
7. Reulen RC, Winter DL, Frobisher C et al. Long-term cause-specific mortality among survivors of childhood cancer. JAMA 2010;304(2):172-9.
8. Friedman DL, Whitton J, Leisenring W et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010;102(14):1083-95.
9. Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002;99(12):4257-64.
10. Mulder RL, Kremer LC, van Santen HM et al. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treat Rev 2009;35(7):616-32.
11. Sklar CA, Mertens AC, Mitby P et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 2006;98(13):890-6.
12. Ridola V, Fawaz O, Aubier F et al. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens. Eur J Cancer 2009;45(5): 814-8.
13. Massimino M, Gandola L, Mattavelli F et al. Radiation-induced thyroid changes: a retrospective and a prospective view. Eur J Cancer 2009;45(14):2546-51.
14. Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G. Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Vasc Health Risk Manag 2008;4(4): 825-36.
15. Mulrooney DA, Yeazel MW, Kawashima T et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009;339:b4606.
16. Skinner R. Nephrotoxicity - what do we know and what don't we know? J Pediatr Hematol Oncol 2011;33(2):128-34.
17. Bhatia S, Davies SM, Scott Baker K, Pulsipher MA, Hansen JA. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood - method-ologic challenges. Biol Blood Marrow Transplant 2011;17(10): 1428-35.
18. Langeveld NE, Grootenhuis MA, Voûte PA, de Haan RJ, van den Bos C. Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology 2004;13(12):867-81.